Despite widespread adoption of antimicrobial stewardship programs, the CDC estimates approximately 30 percent of antibiotics used in hospitals are unnecessary or prescribed incorrectly. Sentri7 helps hospitals continuously improve the appropriate use of antibiotics by arming clinicians with information to prevent harm while minimizing drug costs.
The Sentri7 Difference: Proven results for Aultman Hospital
CMS has incorporated Antimicrobial Use and Resistance (AUR) reporting to the National Health and Safety Network (NHSN) as a required element under the Public Health reporting category within the Promoting Interoperability Program beginning in 2024.
To qualify for the Promoting Interoperability program credit, AUR reports must be submitted to the NHSN by a vendor—like Sentri7® Pharmacy AMS—certified for AUR reporting by the ONC and listed on the Certified Health IT Product List (CHPL).
As a validated provider, you can be confident your Antimicrobial Use and Antimicrobial Resistance data submitted by Sentri7 complies with the National Healthcare Safety Network (NHSN) protocols.
NHSN requires all production AU Summary Clinical Document Architecture (CDA) files to contain an SDS Validation ID, which the NHSN provides to each vendor after successful validation.
Are you interested in how Sentri7 can inform continuous improvement, streamline the adoption of policies and procedures, and increase the impact of your pharmacy’s antimicrobial stewardship programs across facilities?
To request a demo and speak with our expert team about Sentri7 and antimicrobial stewardship, please fill out the form.
